Loading...
Monash IVF Group Limited
MVF.AX•ASX
Healthcare
Medical - Diagnostics & Research
A$0.80
A$-0.01(-0.63%)
Monash IVF Group Limited (MVF.AX) Financial Performance & Income Statement Overview
Review Monash IVF Group Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
19.37%
↑ 19.37%
Operating Income Growth
-115.25%
↓ 115.25%
Net Income Growth
-129.89%
↓ 129.89%
Operating Cash Flow Growth
38.38%
↑ 38.38%
Operating Margin
0.80%
↑ 0.80%
Gross Margin
33.28%
↑ 33.28%
Net Profit Margin
-0.85%
↓ 0.85%
ROE
-0.93%
↓ 0.93%
ROIC
0.52%
↑ 0.52%
Monash IVF Group Limited (MVF.AX) Income Statement & Financial Overview
Review Monash IVF Group Limited's (MVF.AX) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $129.52M | $125.70M | $110.27M | $103.32M |
| Cost of Revenue | $87.48M | $87.84M | $77.23M | $72.95M |
| Gross Profit | $42.04M | $37.86M | $33.04M | $30.37M |
| Gross Profit Ratio | $0.32 | $0.30 | $0.30 | $0.29 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $9.77M | $17.59M | $14.80M | $13.57M |
| Operating Expenses | $67.66M | $17.59M | $14.80M | $13.57M |
| Total Costs & Expenses | $155.14M | $105.43M | $92.03M | $86.52M |
| Interest Income | $31000.00 | $25000.00 | $23000.00 | $2000.00 |
| Interest Expense | $2.81M | $2.55M | $1.70M | $1.60M |
| Depreciation & Amortization | -$3.02M | $9.69M | $7.38M | $7.96M |
| EBITDA | -$27.87M | $29.96M | $24.16M | $24.32M |
| EBITDA Ratio | -$0.22 | $0.24 | $0.23 | $0.24 |
| Operating Income | -$25.62M | $20.27M | $18.23M | $16.80M |
| Operating Income Ratio | -$0.20 | $0.16 | $0.17 | $0.16 |
| Other Income/Expenses (Net) | -$2.78M | -$2.53M | -$3.15M | -$2.05M |
| Income Before Tax | -$28.40M | $17.75M | $15.08M | $14.76M |
| Income Before Tax Ratio | -$0.22 | $0.14 | $0.14 | $0.14 |
| Income Tax Expense | -$9.57M | $4.87M | $3.96M | $3.92M |
| Net Income | -$19.30M | $12.77M | $11.20M | $10.64M |
| Net Income Ratio | -$0.15 | $0.10 | $0.10 | $0.10 |
| EPS | -$0.05 | $0.03 | $0.03 | $0.03 |
| Diluted EPS | -$0.05 | $0.03 | $0.03 | $0.03 |
| Weighted Avg Shares Outstanding | $384.03M | $389.63M | $389.63M | $389.63M |
| Weighted Avg Shares Outstanding (Diluted) | $389.63M | $392.68M | $392.03M | $392.84M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan